-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Aptose Biosciences Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2017 to Q3 2024.
- Aptose Biosciences Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $4K, a 80% decline year-over-year.
- Aptose Biosciences Inc. Depreciation, Depletion and Amortization for the twelve months ending September 30, 2024 was $46K, a 53.1% decline year-over-year.
- Aptose Biosciences Inc. annual Depreciation, Depletion and Amortization for 2023 was $88K, a 26.7% decline from 2022.
- Aptose Biosciences Inc. annual Depreciation, Depletion and Amortization for 2022 was $120K, a 20% decline from 2021.
- Aptose Biosciences Inc. annual Depreciation, Depletion and Amortization for 2021 was $150K, a 1.32% decline from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)